Anti-HLA-DR 抗体 [EPR3692] (ab92511)

ab92511 は 9 報の論文で使用されています。

• Yang M  et al. An obligatory anaerobicSalmonella typhimuriumstrain redirects M2 macrophages to the M1 phenotype. Oncol Lett 15:3918-3922 (2018). PubMed: 29456740
• He R  et al. Link Protein N-Terminal Peptide as a Potential Stimulating Factor for Stem Cell-Based Cartilage Regeneration. Stem Cells Int 2018:3217895 (2018). PubMed: 29531532
• Imai D  et al. The prognostic impact of programmed cell death ligand 1 and human leukocyte antigen class I in pancreatic cancer. Cancer Med 6:1614-1626 (2017). IHC-P ; Human . PubMed: 28602029
• Watanabe N  et al. A cell-based high-throughput screening assay system for inhibitor compounds of antigen presentation by HLA class II molecule. Sci Rep 7:6798 (2017). PubMed: 28754892
• Mastropasqua R  et al. Corneoscleral limbus in glaucoma patients: in vivo confocal microscopy and immunocytological study. Invest Ophthalmol Vis Sci 56:2050-8 (2015). PubMed: 25744981
• Wang H  et al. CD68(+)HLA-DR(+) M1-like macrophages promote motility of HCC cells via NF-?B/FAK pathway. Cancer Lett 345:91-9 (2014). IHC-P ; Human . PubMed: 24333724
• Steain M  et al. Analysis of T cell responses during active varicella-zoster virus reactivation in human ganglia. J Virol 88:2704-16 (2014). PubMed: 24352459
• Shimizu C  et al. The role of TGF-ß and myofibroblasts in the arteritis of Kawasaki disease. Hum Pathol 44:189-98 (2013). PubMed: 22955109
• Deora A  et al. Transmembrane TNF-dependent uptake of anti-TNF antibodies. MAbs 9:680-695 (0). PubMed: 28323513